Wu J - Search Results

1

Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer.

Liu X, Lai L, Wang X, Xue L, Leora S, Wu J, Hu S, Zhang K, Kuo ML, Zhou L, Zhang H, Wang Y, Wang Y, Zhou B, Nelson RA, Zheng S, Zhang S, Chu P, Yen Y. Liu X, et al. Among authors: wu j. Cancer Res. 2011 May 1;71(9):3202-13. doi: 10.1158/0008-5472.CAN-11-0054. Epub 2011 Mar 17. Cancer Res. 2011. PMID: 21415168 Free PMC article.

2

p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.

Zhang K, Wu J, Wu X, Wang X, Wang Y, Zhou N, Kuo ML, Liu X, Zhou B, Chang L, Ann D, Yen Y. Zhang K, et al. Among authors: wu x, wu j. Mol Cancer Ther. 2011 Feb;10(2):269-78. doi: 10.1158/1535-7163.MCT-10-0728. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216934 Free PMC article.

3

A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Zhou B, Su L, Hu S, Hu W, Yip ML, Wu J, Gaur S, Smith DL, Yuan YC, Synold TW, Horne D, Yen Y. Zhou B, et al. Among authors: wu j. Cancer Res. 2013 Nov 1;73(21):6484-93. doi: 10.1158/0008-5472.CAN-13-1094. Epub 2013 Sep 26. Cancer Res. 2013. PMID: 24072748 Free PMC article.

4

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, Yen Y, Wang Y, Marcusson EG, Chu P, Wu J, Wu X, Li AX, Li Z, Gao H, Ren X, Boldin MP, Lin PC, Wang SE. Zhou W, et al. Among authors: wu x, wu j. Cancer Cell. 2014 Apr 14;25(4):501-15. doi: 10.1016/j.ccr.2014.03.007. Cancer Cell. 2014. PMID: 24735924 Free PMC article.

5

The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.

Chen MC, Zhou B, Zhang K, Yuan YC, Un F, Hu S, Chou CM, Chen CH, Wu J, Wang Y, Liu X, Smith DL, Li H, Liu Z, Warden CD, Su L, Malkas LH, Chung YM, Hu MC, Yen Y. Chen MC, et al. Among authors: wu j. Mol Pharmacol. 2015 Jun;87(6):996-1005. doi: 10.1124/mol.114.094987. Epub 2015 Mar 26. Mol Pharmacol. 2015. PMID: 25814515 Free PMC article.

6

Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis.

Zhang K, Hu S, Wu J, Chen L, Lu J, Wang X, Liu X, Zhou B, Yen Y. Zhang K, et al. Among authors: wu j. Mol Cancer. 2009 Feb 28;8:11. doi: 10.1186/1476-4598-8-11. Mol Cancer. 2009. PMID: 19250552 Free PMC article.

7

Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.

Kretzner L, Scuto A, Dino PM, Kowolik CM, Wu J, Ventura P, Jove R, Forman SJ, Yen Y, Kirschbaum MH. Kretzner L, et al. Among authors: wu j. Cancer Res. 2011 Jun 1;71(11):3912-20. doi: 10.1158/0008-5472.CAN-10-2259. Epub 2011 Apr 18. Cancer Res. 2011. PMID: 21502403 Free PMC article.

8

CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

Tsuyada A, Chow A, Wu J, Somlo G, Chu P, Loera S, Luu T, Li AX, Wu X, Ye W, Chen S, Zhou W, Yu Y, Wang YZ, Ren X, Li H, Scherle P, Kuroki Y, Wang SE. Tsuyada A, et al. Among authors: wu x, wu j. Cancer Res. 2012 Jun 1;72(11):2768-79. doi: 10.1158/0008-5472.CAN-11-3567. Epub 2012 Apr 3. Cancer Res. 2012. PMID: 22472119 Free PMC article.

9

Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.

Meng Z, Li T, Ma X, Wang X, Van Ness C, Gan Y, Zhou H, Tang J, Lou G, Wang Y, Wu J, Yen Y, Xu R, Huang W. Meng Z, et al. Among authors: wu j. Mol Cancer Ther. 2013 Oct;12(10):2067-77. doi: 10.1158/1535-7163.MCT-13-0314. Epub 2013 Aug 19. Mol Cancer Ther. 2013. PMID: 23960096 Free PMC article.

10

G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.

Sun T, Zhang K, Pangeni RP, Wu J, Li W, Du Y, Guo Y, Chaurasiya S, Arvanitis L, Raz DJ. Sun T, et al. Among authors: wu j. Mol Cancer Res. 2021 Mar;19(3):429-440. doi: 10.1158/1541-7786.MCR-20-0557. Epub 2020 Dec 9. Mol Cancer Res. 2021. PMID: 33298547 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72,545 results

Search Page